Calley Means, a MAHA leader who just resigned from the Trump administration, says Americans "are being duped and gaslighted ...

The Trump administration is facing another lawsuit over its sweeping changes to Medicaid less than a week after a federal ...

Democrats are likely to focus on reversing Medicaid cuts and expanding insurance coverage, giving a boost to health care ...

For AI to achieve its full potential in women’s health, medical records need to tell the complete story,” experts write.

Few Americans are familiar with kratom, despite public health messaging and rising use. So what is it, and who's using it?

Novartis acknowledged seven instances of tumors being found in children who were treated with Zolgensma for spinal muscular ...

People with cognitively unimpaired Alzheimer’s “may be asymptomatic, but they do have a disease experience,” writes Jason ...

Two newly elected lawmakers with science backgrounds hope to push back against Trump administration cuts to health equity programs.

New cases show AAV gene therapies like Zolgensma carry tumor risks, raising key concerns for SMA patients and gene therapy researchers in general.

Voters in 2026 midterm elections decided state health policy ballot measures on abortion rights, marijuana laws, science ...

Medicare pushed forward a controversial plan to ban hospitals from using third parties to deliver remote patient monitoring services, despite overwhelming opposition.

Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.